Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery.

Area of Science:

• Stem cell biology
• Drug discovery and development
• Translational medicine

Background:

• A significant hurdle in drug discovery is the poor translation of preclinical research findings into successful clinical outcomes.
• Physiological in vitro systems are increasingly important for overcoming these translational challenges.
• Induced pluripotent stem cells (iPSCs) offer a promising avenue for generating human cell types for advanced cellular assay models.

Purpose of the Study:

• To address the complexities of utilizing induced pluripotent stem cells (iPSCs) in drug discovery.
• To provide practical guidance on the cultivation, differentiation, and quality control of iPSCs for reliable assay development.
• To enhance the utility of iPSC-derived models for more disease-relevant preclinical testing.

Main Methods:

• Detailed protocols for the cultivation of human induced pluripotent stem cells (iPSCs).
• Established differentiation methods to generate specific human cell types from iPSCs.
• Implementation of rigorous quality control measures for iPSC lines and differentiated cells.

Main Results:

• Successful generation of various human cell types from iPSCs suitable for drug discovery assays.
• Defined critical parameters for consistent iPSC cultivation and differentiation.
• Established robust quality control benchmarks to ensure the reliability of iPSC-based models.

Conclusions:

• Induced pluripotent stem cells (iPSCs) are valuable tools for creating more predictive in vitro models in drug discovery.
• Standardized protocols for iPSC handling, differentiation, and quality control are essential for successful implementation.
• This work facilitates the broader adoption of iPSC technology to improve the efficiency and success rate of drug development.